Pathophysiology and Treatment of Gout Arthritis; including Gout Arthritis of Hip Joint: A Literature Review

키워드

참고문헌 (67)

1. Clebak KT, "Gout : rapid evidence review", Am Fam Physician, 102, pp.533~538 (2020)
2. Kim Y, "Diagnosis and treatment of inflammatory joint disease", Hip Pelvis, 29, pp.211~222 (2017)[DOI]
3. Roddy E, "Revisiting the pathogenesis of podagra : why does gout target the foot?", J Foot Ankle Res, 4, pp.13~ (2011)[DOI]
4. Galozzi P, "Autoinflammatory features in gouty arthritis", J Clin Med, 10, pp.1880~ (2021)[DOI]
5. Dalbeth N, "Gout", Lancet, 388, pp.2039~2052 (2016)[DOI]
6. Ragab G, "Gout : an old disease in new perspective-a review", J Adv Res, 8, pp.495~511 (2017)[DOI]
7. Kuo CF, "Global epidemiology of gout : prevalence, incidence and risk factors", Nat Rev Rheumatol, 11, pp.649~662 (2015)[DOI]
8. Kamei K, "A slight increase within the normal range of serum uric acid and the decline in renal function : associations in a community-based population", Nephrol Dial Transplant, 29, pp.2286~2292 (2014)[DOI]
9. McCarty DJ, "Identification of urate crystals in gouty synovial fluid", Ann Intern Med, 54, pp.452~460 (1961)[DOI]
10. Emmerson BT, "The management of gout", N Engl J Med, 334, pp.445~451 (1996)[DOI]
11. Mandal AK, "The molecular physiology of uric acid homeostasis", Annu Rev Physiol, 77, pp.323~345 (2015)[DOI]
12. Ichida K, "Decreased extra-renal urate excretion is a common cause of hyperuricemia", Nat Commun, 3, pp.764~ (2012)[DOI]
13. Enomoto A, "Roles of organic anion transporters(OATs)and a urate transporter(URAT1)in the pathophysiology of human disease", Clin Exp Nephrol, 9, pp.195~205 (2005)[DOI]
14. Kolz M, "Meta-analysis of 28, 141 individuals identifies common variants within five new loci that influence uric acid concentrations", PLoS Genet, 5, pp.e1000504~ (2009)[DOI]
15. Phipps-Green AJ, "Twentyeight loci that influence serum urate levels : analysis of association with gout", Ann Rheum Dis, 75, pp.124~130 (2016)[DOI]
16. Emmerson B, "Hyperlipidaemia in hyperuricaemia and gout", Ann Rheum Dis, 57, pp.509~510 (1998)[DOI]
17. Kanbara A, "Effect of urine pH on uric acid excretion by manipulating food materials", Nucleosides Nucleotides Nucleic Acids, 30, pp.1066~1071 (2011)[DOI]
18. Towiwat P, "The association of vitamin C, alcohol, coffee, tea, milk and yogurt with uric acid and gout", Int J Rheum Dis, 18, pp.495~501 (2015)[DOI]
19. Desai J, "Molecular pathophysiology of gout", Trends Mol Med, 23, pp.756~768 (2017)[DOI]
20. Zhang W, "EULAR evidence based recommendations for gout. Part II : management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics(ESCISIT)", Ann Rheum Dis, 65, pp.1312~1324 (2006)[DOI]
21. Hamburger M, "2011 recommendations for the diagnosis and management of gout and hyperuricemia", Postgrad Med, 123(6 Suppl 1), pp.3~36 (2011)[DOI]
22. Sivera F, "Multinational evidencebased recommendations for the diagnosis and management of gout : integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3e initiative", Ann Rheum Dis, 73, pp.328~335 (2014)[DOI]
23. Graf SW, "Australian and New Zealand recommendations for the diagnosis and management of gout : integrating systematic literature review and expert opinion in the 3e Initiative", Int J Rheum Dis, 18, pp.341~351 (2015)[DOI]
24. Neogi T, "2015 Gout classification criteria : an American College of Rheumatology", European League Against Rheumatism collaborative initiative, 2015, pp.74, 1789~1798
25. Multi-Disciplinary Expert Task Force on Hyperuricemia and Its Related Diseases, "Chinese multi-disciplinary consensus on the diagnosis and treatment of hyperuricemia and its related diseases", Zhonghua Nei Ke Za Zhi, 56, pp.235~248 (2017)[DOI]
26. Qaseem A, "Diagnosis of acute gout : a clinical practice guideline from the American College of Physicians", Ann Intern Med, 166, pp.52~57 (2017)[DOI]
27. Qaseem A, "Management of acute and recurrent gout : a clinical practice guideline from the American College of Physicians", Ann Intern Med, 166, pp.58~68 (2017)[DOI]
28. Meyers OL, "Hyperuricaemia and gout : clinical guideline 2003", S Afr Med J, 93(12 Pt 2), pp.961~971 (2003)
29. Manara M, "Italian Society of Rheumatology recommendations for the management of gout", Reumatismo, 65, pp.4~21 (2013)[DOI]
30. Yamanaka H, "Japanese guideline for the management of hyperuricemia and gout : second edition", Nucleosides Nucleotides Nucleic Acids, 30, pp.1018~1029 (2011)[DOI]
31. "Management of gout" (2021)[URL]
32. Sivera F, "Diagnostic value of clinical, laboratory, and imaging findings in patients with a clinical suspicion of gout : a systematic literature review", J Rheumatol Suppl, 92, pp.3~8 (2014)[DOI]
33. Zhang Q, "The diagnostic performance of musculoskeletal ultrasound in gout : a systematic review and meta-analysis", PLoS One, 13, pp.e0199672~ (2018)[DOI]
34. Yu Z, "Diagnostic accuracy of dual-energy CT in gout : a systematic review and meta-analysis", Skeletal Radiol, 47, pp.1587~1593 (2018)[DOI]
35. Roddy E, "Openlabel randomised pragmatic trial(CONTACT)comparing naproxen and low-dose colchicine for the treatment of gout flares in primary care", Ann Rheum Dis, 79, pp.276~284 (2020)[DOI]
36. Rainer TH, "Oral prednisolone in the treatment of acute gout : a pragmatic, multicenter, double-blind, randomized trial", Ann Intern Med, 164, pp.464~471 (2016)[DOI]
37. FitzGerald JD, "2020 American College of Rheumatology guideline for the management of gout", Arthritis Rheumatol, 72, pp.879~895 (2020)[DOI]
38. Terkeltaub RA, "Novel evidence-based colchicine dose-reduction algorithm to predict and prevent colchicine toxicity in the presence of cytochrome P450 3A4", P-glycoprotein inhibitors, 2011, pp.63, 2226~2237
39. Sutaria S, "Effectiveness of interventions for the treatment of acute and prevention of recurrent gout--a systematic review", Rheumatology(Oxford), 45, pp.1422~1431 (2006)[DOI]
40. Schumacher HR, "Efficacy and tolerability of celecoxib in the treatment of acute gouty arthritis : a randomized controlled trial", J Rheumatol, 39, pp.1859~1866 (2012)[DOI]
41. Richette P, "2016 updated EULAR evidence-based recommendations for the management of gout", Ann Rheum Dis, 76, pp.29~42 (2017)[DOI]
42. Yamanaka H, "Stepwise dose increase of febuxostat is comparable with colchicine prophylaxis for the prevention of gout flares during the initial phase of uratelowering therapy : results from FORTUNE-1, a prospective, multicentre randomised study", Ann Rheum Dis, 77, pp.270~276 (2018)[DOI]
43. Borstad GC, "Colchicine for prophylaxis of acute flares when initiating allopurinol for chronic gouty arthritis", J Rheumatol, 31, pp.2429~2432 (2004)
44. Becker MA, "The uratelowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout : the CONFIRMS trial", Arthritis Res Ther, 12, pp.R63~ (2010)[DOI]
45. Kim JW, "Prescription pattern of uratelowering therapy in Korean gout patients : data from the national health claims database", Korean J Intern Med, 33, pp.228~229 (2018)[DOI]
46. Pillinger MH, "Therapeutic approaches in the treatment of gout", Semin Arthritis Rheum, 50(3S), pp.S24~S30 (2020)[DOI]
47. Stamp LK, "A randomised controlled trial of the efficacy and safety of allopurinol dose escalation to achieve target serum urate in people with gout", Ann Rheum Dis, 76, pp.1522~1528 (2017)[DOI]
48. Son CN, "Global patterns of treat-to-serum urate target care for gout : systematic review and meta-analysis", Semin Arthritis Rheum, 51, pp.677~684 (2021)[DOI]
49. Mackenzie IS, "Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout(FAST) : a multicentre, prospective, randomised, open-label, non-inferiority trial", Lancet, 396, pp.1745~1757 (2020)[DOI]
50. Pascart T, "2020 recommendations from the French Society of Rheumatology for the management of gout : Urate-lowering therapy", Joint Bone Spine, 87, pp.395~404 (2020)[DOI]
51. Chung WK, "Treatment of septic arthritis of the hip by arthroscopic lavage", J Pediatr Orthop, 13, pp.444~446 (1993)[DOI]
52. Hadler NM, "Acute polyarticular gout", Am J Med, 56, pp.715~719 (1974)[DOI]
53. Huang Y, "Treatment of atypical gouty arthritis of the hip using total hip arthroplasty : a case report", Medicine(Baltimore), 99, pp.e23027~ (2020)[DOI]
54. Schlesinger N, "The pathogenesis of bone erosions in gouty arthritis", Ann Rheum Dis, 69, pp.1907~1912 (2010)[DOI]
55. Pascual E, "Synovial fluid analysis for crystals", Curr Opin Rheumatol, 23, pp.161~169 (2011)[DOI]
56. Zhu L, "Combining hyperechoic aggregates and the double-contour sign increases the sensitivity of sonography for detection of monosodium urate deposits in gout", J Ultrasound Med, 36, pp.935~940 (2017)[DOI]
57. Di Matteo A, "Ultrasound and clinical features of hip involvement in patients with gout", Joint Bone Spine, 86, pp.633~636 (2019)[DOI]
58. Xu S, "Gout presenting as acute hip pain in a young woman : a case report", JBJS Case Connect, 9, pp.e11~ (2019)[DOI]
59. Tolin MC, "Severe hip and knee pain in a man with chronic tophaceous gout", Int J Rheum Dis, 12, pp.57~60 (2009)[DOI]
60. Shah L, "Adverse reaction to metal debris with accompanying gout and amyloid deposits in hip arthroplasty", Radiol Case Rep, 18, pp.1005~1009 (2023)[DOI]
61. Parisien RL, "Pathologic hip fracture by virtue of a rare osseous manifestation of gout : a case report", JBJS Case Connect, 10, pp.e20.00231~ (2020)[DOI]
62. Braun T, "Pathways for bone loss in inflammatory disease", Curr Osteoporos Rep, 10, pp.101~108 (2012)[DOI]
63. Lee YM, "IL-1plays an important role in the bone metabolism under physiological conditions", Int Immunol, 22, pp.805~816 (2010)[DOI]
64. Chen W, "Uric acid suppresses 1 alpha hydroxylase in vitro and in vivo", Metabolism, 63, pp.150~160 (2014)[DOI]
65. Hui JY, "The independent association between parathyroid hormone levels and hyperuricemia : a national population study", Arthritis Res Ther, 14, pp.R56~ (2012)[DOI]
66. Paik JM, "Gout and risk of fracture in women : a prospective cohort study", Arthritis Rheumatol, 69, pp.422~428 (2017)[DOI]
67. Kim SC, "Gout and the risk of non-vertebral fracture", J Bone Miner Res, 32, pp.230~236 (2017)[DOI]

관련 논문AI추천